Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer (NSCLC)
2 clinical trials · Condition
◉ Watch Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer (NSCLC)
| Record | Firm | Date |
|---|---|---|
| Medical Access Program for Patritumab Deruxtecan (NCT06099639) | Daiichi Sankyo |
Track Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer (NSCLC) automatically
Every clearance here is in the API, with alerts when new ones post.